Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Non-cash Items (2020)

Design Therapeutics' Non-cash Items history spans 1 years, with the latest figure at $8.5 million for Q4 2020.

  • For Q4 2020, Non-cash Items changed N/A year-over-year to $8.5 million; the TTM value through Dec 2020 reached $8.5 million, changed N/A, while the annual FY2020 figure was $8.5 million, N/A changed from the prior year.
  • Non-cash Items for Q4 2020 was $8.5 million at Design Therapeutics.
  • Across five years, Non-cash Items topped out at $8.5 million in Q4 2020 and bottomed at $8.5 million in Q4 2020.